Company Filing History:
Years Active: 1999-2006
Title: The Innovative Contributions of Theresa J Goletz
Introduction
Theresa J Goletz is a notable inventor based in Kensington, MD (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 3 patents to her name, her work has the potential to impact public health positively.
Latest Patents
One of her latest patents focuses on targeting antigens to the MHC class I processing pathway using an anthrax toxin fusion protein. This invention provides a vaccine designed to induce an immune response in mammals to a specific antigen. The vaccine comprises a unit dose of a binary toxin protective antigen and the antigen, which is bound to a binary toxin protective antigen binding protein. In another embodiment, the vaccine includes an anthrax protective antigen and the antigen bound to an anthrax protective antigen binding protein. This patent also outlines methods for immunizing mammals against an antigen and inducing antigen-presenting mammalian cells to present specific antigens via the MHC class I processing pathway.
Another patent by Goletz also addresses the same theme of targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein. This invention provides a vaccine that includes a binary, cytotoxic T lymphocyte vaccine comprising an anthrax protective antigen and a full-length protein antigen bound to a nontoxic anthrax protective antigen binding protein. This patent further elaborates on methods for immunization and antigen presentation.
Career Highlights
Throughout her career, Theresa J Goletz has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the United States of America as represented by the Department of Health. Her work in these institutions has allowed her to contribute significantly to public health initiatives.
Collaborations
Theresa has collaborated with notable professionals in her field, including Jay A Berzofsky and Kurt Klimpel. These collaborations have likely enriched her research and development efforts.
Conclusion
Theresa J Goletz is a pioneering inventor whose work in vaccine development has the potential to advance immunological research and public health. Her innovative patents reflect her commitment to improving health outcomes through scientific discovery.